Joe Newell - Nov 16, 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Chief Operations Officer
Signature
/s/ David Tucker, Attorney-in-Fact for Joe Newell
Stock symbol
ATRA
Transactions as of
Nov 16, 2021
Transactions value $
-$57,034
Form type
4
Date filed
11/18/2021, 04:54 PM
Previous filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$57K -3.33K -2.86% $17.12* 113K Nov 16, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2021 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. The prices actually received ranged from $16.45 to $17.3823. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold on behalf of the group at each price within the range.